-
The University of Tokyo and Chitose Laboratory Drive New Development in Digital Design for Manufacturing Process of Antibody Drugs ―Mathematical model development of cultivation process with full utilization of data from automated experiments―
-
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
-
High-Performance Novel HAT Cell Line for Gene Therapy, Published in Molecular Therapy Methods & Clinical Development, and Ready for Commercial Use
-
CHITOSE’s AI Doubles Protein Productivity in Filamentous Fungi Compared to Best Human-Designed Conditions
-
Paper on Novel CHO-MK Cell Line Receives 2025 Excellent Paper Award from the Society of Biotechnology, Japan
-
CHITOSE Group Forms Capital and Business Alliance with TOPPAN Holdings
-
Media / Editorial
2024.10.04
CHITOSE AI-Powered Bioproduction Management System Featured in Focus NEDO No. 92
-
Media / Editorial
2024.07.31
Research Paper Published on CHO-MK: Novel Host Cell Line for Biopharmaceutical Manufacturing
-
MYCENAX and Chitose Laboratory Corp. to Scale-Up Production and Strengthen Marketing Activities for CHO-MK Cells
-
Media / Editorial
2019.10.03
The American Chemical Society’s newsletter, Chemical and Engineering News (C&EN), introduced CHITOSE GROUP’s fermentation-related business
